Eastnine

Eastnine

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Eastnine - Warsaw to become the largest market

14 juli 2026

  • Q2 report broadly in line with expectations
  • The Bridge deal is the largest incremental news
  • Significant earnings growth in 2027/2028e

Q2 report wrap

Eastnine's Q2 report saw rental income and NOI in line with expectations, while rec PTP was burdened by the large cash position and costs related to build-up of the organisation in Poland. The occupancy rate surprised positively and came in at 96.5% (+0.9pp q-o-q) while earnings capacity contracted sequentially on the Riga divestments, as expected.

The Bridge drives estimate revisions

As we highlighted in our fast comment last Tuesday, Eastnine has acquired The Bridge in central Warsaw with a rental value of EUR 18.2m at an underlying property value of EUR 300m. The occupancy rate is 92% and the deal will be financed with existing cash, new debt, and refinancings of the existing portfolio. We understand that the purchase price of EUR 260m is lower than the property value of EUR 300m due to remaining tenant adaptations (~EUR 15m), deductions for initial vacancies (e.g. Visa will move in during 2027) and rental discounts. Management sounds confident that the letting ratio will surpass the current 92% at completion (Q4'26e), but tenants will move in gradually, meaning that the reported occupancy will come down initially while the full effect from the acquisition will only start to show in 2028e.

Prime assets but with high yields

Unlike the Swedish office market, Eastnine's core markets are seeing strong GDP growth, low office vacancies and positive rent reversion. Supply growth is falling and demand remains solid. We expect this to fuel stronger like-for-like rental income growth than Swedish peers, and significantly better cash flow, especially after maintenance capex. At a normalised cash ROE (CEPS/EPRA NRV) of ~6.7%, the returns are more comparable to Swedish industrial companies (Catena/Sagax/SLP at ~7%) than office companies (Atrium Ljungberg, Fabege, Hufvudstaden at ~3%), but with prime CBD assets.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-08-25 Isofol Medical - Maximising the dose before Phase 2 Isofol Medical Analys
2026-08-24 Skolon - Broad-based growth continues Skolon Analys
2026-08-24 Gentoo Media - FCF generation remains top priority Gentoo Media Analys
2026-08-24 Impact Coatings - Backlog to carry H2e Impact Coat.. Analys
2026-08-24 I-tech - Beyond a single molecule I-tech Analys
2026-08-23 Catella - Signs of improvement, but delivery stil... Catella Analys
2026-08-23 Ogunsen - Some signs of stabilisation Ogunsen Analys
2026-08-21 Clavister - Strong quarter strengthens the outlook Clavister Analys
2026-08-21 Generic - Investing while growing Generic Analys
2026-08-21 Impact Coatings - A quarter driven by Coating Ser... Impact Coat.. Analys
2026-08-21 Skolon - Sweden profitability gains continue Skolon Analys
2026-08-21 I-tech - Strongest quarter on record I-tech Analys
2026-08-20 Tempest Security - Patrols below plan Tempest Sec.. Analys
2026-08-20 Tempest Security - Progress made but expectations... Tempest Sec.. Analys
2026-08-20 Ascelia Pharma - Still alive: Fighting to reverse... Ascelia Pharma Analys
2026-08-20 Clavister - Defence drives record quarter Clavister Analys
2026-08-20 Catella - Q2 softer than expected, but underlying... Catella Analys
2026-08-20 Generic - Volumes continue to grow Generic Analys
2026-08-19 SinterCast - Past the trough, but recovery pace u... SinterCast Analys
2026-08-19 Xplora Technologies - EBITDA -13% on soft senior ... Xplora Tech.. Analys